61.69 USD
↘ 1.11 (1.77%)LIVE (AS OF 11:34 AM EST)
Bristol-Myers Squibb Co. (BMY) trades at $61.69 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Key drivers include exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 10, 2026.